The Use of HAART Is Associated With Decreased Risk of Death During Initial Treatment of Cryptococcal Meningitis in Adults in Botswana

Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0b013e318183181e
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

The Use of Mannitol in HIV-infected Patients With Symptomatic Cryptococcal Meningitis

Drug discoveries & therapeutics
MedicineToxicologyPharmaceuticsPharmacology
2016English

Risk Factors in HIV/AIDS Patients With Cryptococcal Meningitis

BMC Infectious Diseases
Infectious Diseases
2014English

Ophthalmic Signs in Ugandan Adults With HIV-associated Cryptococcal Meningitis: A Nested Analysis of the ASTRO-CM Cohort

Wellcome Open Research
BiochemistryMedicineGeneticsMolecular Biology
2018English

Emerging Concepts in HIV-associated Cryptococcal Meningitis

Current Opinion in Infectious Diseases
Infectious DiseasesMicrobiology
2019English

Factors Associated With Early Mycological Clearance in HIV-associated Cryptococcal Meningitis

PLoS ONE
Multidisciplinary
2017English

Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults With Cryptococcal Meningitis.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Cryptococcal Meningitis Associated With Increased Adenosine Deaminase in the Cerebrospinal Fluid

SpringerPlus
Multidisciplinary
2016English

Effect of Oral Fluconazole 1200 Mg/Day on QT Interval in African Adults With HIV-associated Cryptococcal Meningitis

AIDS
Infectious DiseasesAllergyImmunology
2018English

Hyponatremia as the Initial Presentation of Cryptococcal Meningitis After Liver Transplantation

Hepatitis Monthly
HepatologyInfectious Diseases
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy